While Intuitive Surgical (ISRG 0.22%) shares have bounced back from Thursday's late day sell-off, investors are still left with more questions than they have answers. In the following video, Brenton Flynn outlines yesterday's news and provides one reason to be optimistic around the outcome of this FDA inquiry. In the spirit of balance, he also offers one fact that gives him pause about investing in the stock.
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Intuitive's FDA Inquiry: Nightmare or Noise?
NASDAQ: ISRG
Intuitive Surgical

Two different views on the FDA's inquiry into the daVinci surgical robot.
Brenton Flynn has no position in any stocks mentioned. The Motley Fool recommends Intuitive Surgical. The Motley Fool owns shares of Intuitive Surgical and Medtronic. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Stocks Mentioned

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Related Articles





Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.